Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticoagulation regimens for thalidomide and lenalidomide

Maurizio Zangari1

  • 1University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy, Little Rock, AR 72205, USA.

Clinical Advances in Hematology & Oncology : H&O
|November 14, 2006
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.

Blood cancer journal·2026
Same author

Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myeloma.

Blood cancer journal·2026
Same author

Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study.

Blood cancer journal·2025
Same author

Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans.

Blood cancer journal·2025
Same author

Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition.

Experimental hematology & oncology·2025
Same author

The efficacy of teclistamab in patients with multiple myeloma and secondary plasma cell leukemia.

Blood advances·2025